Efficacy and Safety of DVC1-0101 for Intermittent Claudication Secondary to Peripheral Artery Disease: Study Protocol of a Randomized Phase IIb Trial

Michiko Tanaka^1*, Takuya Matsumoto², Koichi Morisaki², Ryoichi Kyuragi², Yuriko Fujino¹, Kumi Yoshida¹, Yoshikazu Yonemitsu¹ and Yoshihiko Maehara²

¹R&D Laboratory for Innovative Biotherapeutics, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan

²Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

^*Corresponding Author: Michiko Tanaka, R&D Laboratory for Innovative Biotherapeutics, Graduate School of Pharmaceutical Sciences, Kyushu University, Rm 601, Station II For Collaborative Research 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan, Tel: +81-92-642-6310, Fax: +81-92-642-6834 Email: